Torrens M - Search Results

1

Papaseit E, Pérez-Mañá C, Pérez-Acevedo AP, Hladun O, Torres-Moreno MC, Muga R, Torrens M, Farré M. Papaseit E, et al. Among authors: torrens m. Int J Med Sci. 2018 Aug 6;15(12):1286-1295. doi: 10.7150/ijms.27087. eCollection 2018. Int J Med Sci. 2018. PMID: 30275754 Free PMC article. Review.

2

Flunitrazepam consumption among heroin addicts admitted for in-patient detoxification.

San L, Tato J, Torrens M, Castillo C, Farré M, Camí J. San L, et al. Among authors: torrens m. Drug Alcohol Depend. 1993 May;32(3):281-6. doi: 10.1016/0376-8716(93)90093-6. Drug Alcohol Depend. 1993. PMID: 8102333

3

Abuse liability of flunitrazepam among methadone-maintained patients.

Farré M, Terán MT, Roset PN, Mas M, Torrens M, Camí J. Farré M, et al. Among authors: torrens m. Psychopharmacology (Berl). 1998 Dec;140(4):486-95. doi: 10.1007/s002130050793. Psychopharmacology (Berl). 1998. PMID: 9888625 Clinical Trial.

4

3,4-Methylenedioxymethamphetamine (ecstasy) and alcohol interactions in humans: psychomotor performance, subjective effects, and pharmacokinetics.

Hernández-López C, Farré M, Roset PN, Menoyo E, Pizarro N, Ortuño J, Torrens M, Camí J, de La Torre R. Hernández-López C, et al. Among authors: torrens m. J Pharmacol Exp Ther. 2002 Jan;300(1):236-44. doi: 10.1124/jpet.300.1.236. J Pharmacol Exp Ther. 2002. PMID: 11752122 Clinical Trial.

5

Retention rate and illicit opioid use during methadone maintenance interventions: a meta-analysis.

Farré M, Mas A, Torrens M, Moreno V, Camí J. Farré M, et al. Among authors: torrens m. Drug Alcohol Depend. 2002 Feb 1;65(3):283-90. doi: 10.1016/s0376-8716(01)00171-5. Drug Alcohol Depend. 2002. PMID: 11841899

6

Maintenance buprenorphine for opioid users.

Farré M, Torrens M. Farré M, et al. Among authors: torrens m. Lancet. 2003 May 31;361(9372):1906-7; author reply 1907-8. doi: 10.1016/S0140-6736(03)13512-X. Lancet. 2003. PMID: 12788595 No abstract available.

7

[Differences in the subjective effects of drugs in patients with a first psychotic episode. Preliminary results].

Busquets E, Torrens M, Soler A, Farré M, Bulbena A. Busquets E, et al. Among authors: torrens m. Actas Esp Psiquiatr. 2005 Jan-Feb;33(1):19-25. Actas Esp Psiquiatr. 2005. PMID: 15704027 Spanish.

8

Efficacy of antidepressants in substance use disorders with and without comorbid depression. A systematic review and meta-analysis.

Torrens M, Fonseca F, Mateu G, Farré M. Torrens M, et al. Drug Alcohol Depend. 2005 Apr 4;78(1):1-22. doi: 10.1016/j.drugalcdep.2004.09.004. Epub 2004 Nov 11. Drug Alcohol Depend. 2005. PMID: 15769553 Review.

9

Pharmacological interaction between 3,4-methylenedioxymethamphetamine (ecstasy) and paroxetine: pharmacological effects and pharmacokinetics.

Farré M, Abanades S, Roset PN, Peiró AM, Torrens M, O'Mathúna B, Segura M, de la Torre R. Farré M, et al. Among authors: torrens m. J Pharmacol Exp Ther. 2007 Dec;323(3):954-62. doi: 10.1124/jpet.107.129056. Epub 2007 Sep 21. J Pharmacol Exp Ther. 2007. PMID: 17890444 Clinical Trial.

10

Prevalence of long QTc interval in methadone maintenance patients.

Fonseca F, Marti-Almor J, Pastor A, Cladellas M, Farré M, de la Torre R, Torrens M. Fonseca F, et al. Among authors: torrens m. Drug Alcohol Depend. 2009 Jan 1;99(1-3):327-32. doi: 10.1016/j.drugalcdep.2008.06.018. Epub 2008 Sep 5. Drug Alcohol Depend. 2009. PMID: 18774239

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

320 results

Search Page